[P1–074]: PRECLINICAL DISCOVERY AND DEVELOPMENT OF MEDI1814, A MONOCLONAL ANTIBODY SELECTIVELY TARGETING BETA‐AMYLOID 42 (Aβ42). (1st July 2017) - Billinton, Andy; Newton, Phil; Lloyd, Chris; Groves, Maria; Welsh, Fraser; Bogstedt, Anna; Eketjall, Susanna; McFarlane, Mary; Perkinton, Michael; Narwal, Rajesh; Tan, Keith; Dudley, Amanda; et al.